Comparison of ramosetron with ondansetron for the prevention of post-operative nausea and vomiting in high-risk patients

BACKGROUND AND AIMS: Post-operative nausea and vomiting (PONV) has an 80% incidence in high-risk patients. This is despite the availability of several antiemetic drugs. Selective 5-hydroxytryptamine type 3 (5-HT(3)) receptor antagonists are considered first-line for prophylaxis, ondansetron being th...

Descripción completa

Detalles Bibliográficos
Autores principales: Agarkar, Sandip, Chatterjee, Aparna S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4408650/
https://www.ncbi.nlm.nih.gov/pubmed/25937648
http://dx.doi.org/10.4103/0019-5049.154999

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4408650/
https://www.ncbi.nlm.nih.gov/pubmed/25937648
http://dx.doi.org/10.4103/0019-5049.154999

Ejemplares similares